ナショナル・ビジョン・ホールディングスに関するコメント

$Viking Therapeutics (VKTX.US)$skyrocketed 77% after positive drug trial news Tuesday, leading to what proved to be a strong morning for pharmaceutical stocks.
Here are some top stocks in the sector climbing on drug trial and earnings news:
$Janux Therapeutics (JANX.US)$shares shot up 205% to $36.00 after the company announced updated clinical data for both of its clinical programs, reaching over $1.50B in market cap.
$Ligand Pharmaceuticals (LGND.US)$gained 23%...

Upgrades
• $オートゾーン(AZO.US)$ : Goldman Sachs Upgrades to Buy from Neutral - PT $2,296 (from $1,969)
• $チューイー(CHWY.US)$ : Needham Upgrades to Buy from Hold - PT $55
• $ナショナル・ビジョン・ホールディングス(EYE.US)$ : Goldman Sachs Upgrades to Buy from Neutral - PT $32 (from $31)
• $フレゼニウス・メディカル・ケア(FMS.US)$ : Jefferies Upgrades to Buy from Underperform - PT $33.70 (from $30.30)
• $ギットラブ(GTLB.US)$ : Goldman Sachs Upgrades to Buy from Neutral - ...

$コンチネンタル・リソーシズ(CLR.US)$ – The oil and natural gas producer’s stock rallied 7.4% in the premarket after receiving a $70 per share “take private” bid from Chairman Harold Hamm and his family. The company’s board will establish an independent committee to evaluate the proposal.
$オラクル(ORCL.US)$ – Oracle surged 12% in premarket trading after reporting better-than-expected profit and revenue for its latest quarter. Oracle is seeing strong dema...